Table 2

Fold difference in geometric mean titers of VLP+MAA-immunized group over VLP alone-immunized group.
A.
 HPV cLIA time (weeks)
HPV type
 0
 2
 4
 8
 10
 12
 16
 20
 24
 26
 28
 52
HPV 6
 1.1
 3.2
 2.4
 4.3
 10.0
 12.6
 36.3
 10.9
 6.3
 22.7
 41.9
 4.3
HPV 11
 0.8
 2.9
 2.2
 5.5
 23.5
 18.1
 16.2
 8.2
 6.1
 18.4
 36.8
 5.3
HPV 16
 1.0
 5.2
 8.8
 8.4
 21.4
 15.7
 16.1
 11.4
 17.7
 4.8
 12.7
 6.4
HPV 18
 1.0
 4.8
 13.7
 19.4
 70.5
 18.6
 27.1
 35.4
 26.3
 6.7
 26.8
 26.7
B.
 HPV Total IgG antibodies time (weeks)
HPV type
 0
 2
 4
 8
 10
 12
 16
 20
 24
 26
 28
 52
HPV 6
 1.9
 9.5
 9.5
 13.1
 125.0
 328.3
 125.0
 65.7
 34.4
 34.5
 65.7
 18.1
HPV 11
 1.9
 13.1
 25.0
 25.0
 125.0
 90.6
 125.0
 47.6
 34.5
 34.5
 90.6
 18.1
HPV 16
 0.9
 5.0
 9.5
 6.9
 65.7
 65.7
 90.6
 65.7
 13.1
 13.1
 65.7
 25.0
HPV 18
 0.7
 9.5
 13.1
 25.0
 125.0
 47.6
 65.7
 65.7
 25.0
 47.6
 125.0
 90.6

Ruiz et al. Journal of Immune Based Therapies and Vaccines 2005 3:2   doi:10.1186/1476-8518-3-2